-
July 19, 2007 Lupin FY 2007-08 Q1 Net Profit up 55% to Rs. 784 mn
-
July 18, 2007 Lupin receives DCGI Approval to conduct Combined Phase IIb/III Clinical Trials for it’s herbal Psoriasis NCE
-
July 17, 2007 Lupin Receives US FDA Approval for Amlodipine
-
July 2, 2007 Lupin gets MHRA Approval for Lisinopril in UK
-
June 14, 2007 Lupin receives Final FDA Approval for Trandolapril
-
May 31, 2007 Lupin Receives US FDA Approval for Cefadroxil Capsules
-
May 31, 2007 Lupin and Symbiotec decide not to pursue their MoU
-
May 21, 2007 Lupin receives tentative US FDA Approval for Ziprasidone
-
May 15, 2007 Lupin Receives US FDA Approval for Simvastatin Tablets
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications